Roche Holding (QX) Stock Price - RHHBY

Best deals to access real time data!
SMALL CAP BASIC
Monthly Subscription
for only
$29.03
SMALL CAP PRO
Monthly Subscription
for only
$43.59
Real-Time Alerts for Volume Breakouts, Highs and Lows for OTC Markets and OTCBB
Monthly Subscription
for only
$49.99
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Roche Holding (QX) RHHBY Other OTC Common Stock Roche Holding Ltd S/Adr
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  +0.00 +0.00% 32.20 - - - 32.20 06:01:54
Bid Price Ask Price Spread Spread % News
30.90 35.39 4.49 12.69% - 1
Last Trade Time Type Quantity Stock Price Currency
- - - USD

Roche Holding (QX) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 27.77B 862.56M $ 9.58B - 2.90 702.4M
Short Interest Short % of Out Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
402.25k 0.05% $ - 0.00% - -

more financials information »

Roche Holding (QX) News

Historical RHHBY Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week31.8932.4431.41020.0000456k2M1M0.310.97%
1 Month32.31532.4531.41020.0000456k2M954k-0.115-0.36%
3 Months29.6033.1529.440.0000456k4M1M2.608.78%
6 Months28.9733.1525.250.0000456k5M1M3.2311.15%
1 Year31.80533.7725.250.0000315k8M1M0.3951.24%
3 Years36.6538.540.0005070.0000012M1M-4.45-12.14%
5 Years22.7238.710.0005070.0000012M848k9.4841.73%

Roche Holding (QX) Description

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy. In 2014, the Roche Group employed 88,500 people worldwide, invested 8.9 billion Swiss francs in R&D and posted sales of 47.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit roche.com
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20170427 11:07:58